SNSE icon

Sensei Biotherapeutics
SNSE

Overview Fund Activity

30 hedge funds and large institutions have $4.47M invested in Sensei Biotherapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-9
Holders Change %
-23.08%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
Bridgeway Capital Management
Texas
+$193K
2
Bank of America
Bank of America
North Carolina
+$30.9K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$18K
4
Northern Trust
Northern Trust
Illinois
+$16.1K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$935

Top Sellers

1
Vanguard Group
Vanguard Group
Pennsylvania
-$149K
2
Citadel Advisors
Citadel Advisors
Florida
-$134K
3
Millennium Management
Millennium Management
New York
-$85K
4
Renaissance Technologies
Renaissance Technologies
New York
-$63.9K
5
RCM
RA Capital Management
Massachusetts
-$62K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K -$889 -16 -47%
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
$935 +$935 +30 New
Citadel Advisors
28
Citadel Advisors
Florida
– -$134K -2,969 Closed
Truist Financial
29
Truist Financial
North Carolina
– -$45K -997 Closed
Jane Street
30
Jane Street
New York
– -$32K -696 Closed
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
– -$29K -645 Closed
VF
32
Virtu Financial
New York
– -$25K -561 Closed
Legal & General Group
33
Legal & General Group
United Kingdom
– -$4K -84 Closed
1
2